|
Pacific Therapeutics Ltd. (PT) -
| Industry: | Biotechnology |
| RSP Eligible: | YES |
| Market Maker: | No Market Maker |
 |
   
|
|||||||||||||||||||||||||||||||||||||||
 |
|||||
| Date/Time | Price | Change | Volume | Buyer | Seller |
| May 07, 11:19 | 0.090 | 0.000 | 17,000 | Macquarie | Wolverton |
| May 02, 13:08 | 0.090 | -0.020 | 5,000 | TD Securities | Scotia |
| Apr 30, 13:43 | 0.110 | +0.005 | 6,500 | RBC | Anonymous |
| Apr 30, 13:43 | 0.110 | +0.005 | 19,500 | RBC | Fidelity |
| Apr 30, 13:43 | 0.105 | 0.000 | 24,500 | RBC | RBC |
 |
|
| Issued & Outstanding: | 22,586,829 |
| Reserved for Issuance: | 6,997,058 |
| Thin Float: | No |
|
||||||||||||||||||||
|
||||||||||||||||||||
CNSX announced today a new strategic partnership with Innovate Calgary and Alberta Deal Generator (ADG). Innovate Calgary and CNSX have forged a partnership agreement to enhance and support the technology and startup sector in Canada.
>>>
>>>
CNSX Markets Inc. (“CNSX” or the “Exchange”) completed the second tranche of a financing, the first part of which was announced on December 17, 2012.
>>>
>>>
ALP-Final Assay Results
5/17/2013
5/17/2013
RSS-RESAAS to Attend MRED - May 17, 2013
5/17/2013
5/17/2013